Hot Investor Mandate 6: USA-Based Venture Capital Looks Globally For Pre-Clinical and Early Prototype Technologies

23 Nov

A USA-based international investment group is looking to make equity investments into early stage companies in the life science and technology sectors. The firm makes investments generally ranging from $50,000 to $1,000,000 into companies and is generally involved in 2-4 deals per year. The firm is willing to consider companies around the globe.

The firm is generally open to all areas within the life sciences industry. The firm generally makes investment in the seed and series A stages and as such they are generally looking for companies with pre-clincal or early prototype technologies.

The firm is looking for private or publicly held companies with motivated management teams. The firm looks to take board seats into companies on a case by case basis.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: